Page 330 - parasitology for medical and clinical laboratoryprofessionals

310 INDEX

spread of, 9–10 required in parasitic infections, 4–5, 13 Diphyllobothrium latum and, 170
trematodes (flatworms), 128–132 reservoir, 5, 116 Echinococcus multilocularis and, 209
trichuris trichiura, 22 Human Genome Project, 10 herbivores as, 205
hematoxylin and eosin (H&E), 26 human granulocytic ehrlichiosis (HGE), in life cycle of tapeworm, 210
hematuria, 130, 193 219, 241 Taenia solium and, 168
hemimetabolous, 216 Human Immunodeficiency Virus International Task Force for Disease
hemiptera, 92 (HIV). See HIV (Human Eradication (ITFDE). See
hemoflagellates, 80 Immunodeficiency Virus) ITFDE (International Task
hemolytic anemia, 85 human monocytic ehrlichiosis Force for Disease Eradication)
hemorrhage, 146 (HME), 241 intestinal infections, 65–66
hepatomegaly, 130 human morbidity, 254 intestinal parasites, 7, 20, 35–76
herbivores, 205 Hutchison, William McPhee, 89–90 asymptomatic carriers, 66
Heterophyes heterophyes, 184–186 hyaline shell, 150 Balantidium coli, 37–40
disease transmission, 186 hydatid cysts, 26, 125, 133, 170, 204–211 Blastocystis hominis, 58–59
laboratory diagnosis, 186 hydatid disease, 125, 204–205. See also Chilomastix mesnili, 47–48
life cycle, 185 echinococcosis ciliates, 37–40
morphology, 185 diagnosis and progression of, 208–209 classified as protozoa, 36
overview of, 184–185 symptoms of, 210–211 coccidia of human intestine, 67–72
symptoms, 185 treatment and prevention, 211 Cryptosporidium parvum, 67–69
treatment and prevention, 186 hydatid sand, 207 Dientamoeba fragilis, 40–43
Hippocrates, 11, 13, 139, 164, 204 Hymenolepis diminuta, 173–175 differentiating bacterial dysentery from
Hippocratic Oath, 11 laboratory diagnosis, 174 amebic dysentery, 65
Hirudinea, 224, 225 life cycle, 174 differentiating organisms Trichomonas
Hirudo medicinalis, 224, 225 morphology, 174 hominus and Chilonastix
History of Animals, 164 overview of, 173–174 mesnili, 47–48
histotechnologists, 26 symptoms, 174 Endolimax nana, 60–61
HIV (Human Immunodeficiency Virus), 11 treatment and prevention, 175 Entamoeba coli, 54–57
babesiosis and, 238 Hymenolepis nana, 125, 133, 172–173 Entamoeba dispar, 61–63
intestinal parasites and, 36 disease transmission, 173 Entamoeba hartmanni, 59–60
spread of intestinal helminths and laboratory diagnosis, 173 Entamoeba histolytica, 51–54
protozoa, 10 life cycle, 172–173 enteric amoebae, 51
toxoplasmosis and, 89 morphology, 172 Giardia lamblia, 48–51
transmission of parasitic infections overview of, 172 identifying miscellaneous amoeboid
and, 6 symptoms, 172 infections, 63–64
Hoeppli, Reinhard, 13, 194 treatment and prevention, 173 intestinal amoebiasis and treatment, 66
hookworms, 22, 26, 157–158. See also hypostome, 228 Iodamoeba butschlii, 64
Ancylostoma duodenale; Necator Isospora belli, 70–72
americanus I microsporidia, 72–73
early public health efforts targeting, 123 nonpathogenic flagellates of digestive
history of infections, 122–123 IgE, 131 system, 46–47
infection, 145 immunity, natural and acquired, 255 other amoebal organisms in intestinal
infections in United States, 123–125 immunodeficient, 88 parasitosis, 57–63
life cycle, 124–125 immunological tests, 283 other associated conditions of
overview of, 121–122 incidental hosts, 162 intestinal infections, 65–66
treatment of disease, 123–124 indirect method, 255 other intestinal amoebae, 63
hosts infective stage, 6, 13 pathogenic flagellates of urogenital
accidental, 5, 162 infestations, 3, 6 and intestinal systems, 40–46
dead-end, 207 conditions leading to, 20–21 transmission of, 36
definitive, 5, 13, 162, 174, 206, louse, 8 Trichomonas hominus, 46–48
208–209, 210 morbidity of, 18 Trichomonas tenax, 46–47
incidental, 162 insect repellents, 232–233 Trichomonas vaginalis, 43–46
intermediate, 5, 21, 168, 170, 205, 209 intermediate hosts, 21 intracellular, 228